Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer—study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II

被引：0

作者：

Alfred Gugerell

Ghazaleh Gouya-Lechner

Helmut Hofbauer

Maria Laggner

Franz Trautinger

Gabriele Almer

Anja Peterbauer-Scherb

Marcus Seibold

Wolfram Hoetzenecker

Christiane Dreschl

Michael Mildner

Hendrik Jan Ankersmit

机构：

[1] Medical University of Vienna,Division of Thoracic Surgery

[2] Aposcience AG,Clinical Department for Skin and Venereal Diseases

[3] Universitaetsklinikum St.Poelten,Department of Dermatology and Venerology

[4] Austrian Red Cross Blood Transfusion Service of Upper Austria,Department of Surgery

[5] Kepler University Hospital,Research Division of Biology and Pathobiology of the Skin, Department of Dermatology

[6] Krankenhaus der Elisabethinen Klagenfurt,undefined

[7] Medical University of Vienna,undefined

来源：

Trials | / 22卷

关键词：

Diabetic foot ulcer; Secretome-based therapy; Peripheral blood mononuclear cells; Skin; Inflammation; (Impaired) wound healing; Biological; Hydrogel; Clinical trial protocol; Randomized controlled trial;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: a randomized, double-blind, placebo-controlled, phase II multicenter trial
Liu, X.
Xia, J.
Wang, L.
Song, Y.
Yang, J.
Yan, Y.
Ren, H.
Zhao, G.
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (05) : 569 - 575
[32] Rapamycin treatment for amyotrophic lateral sclerosis Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)
Mandrioli, Jessica
D'Amico, Roberto
Zucchi, Elisabetta
Gessani, Annalisa
Fini, Nicola
Fasano, Antonio
Caponnetto, Claudia
Chio, Adriano
Bella, Eleonora Dalla
Lunetta, Christian
Mazzini, Letizia
Marinou, Kalliopi
Soraru, Gianni
de Biasi, Sara
Lo Tartaro, Domenico
Pinti, Marcello
Cossarizza, Andrea
MEDICINE, 2018, 97 (24)
[33] The Efficacy and Safety of Shen Guo Lao Nian Granule for Common Cold of Qi-Deficiency Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase II Clinical Trial
Liu, Xuemei
Fu, Juanjuan
Fan, Tao
Liu, Wei
Jiang, Hongli
Zhang, Ruiming
Ding, Hong
Yang, Haimiao
Hu, Siyuan
Huang, Yuhong
Li, Guanhong
Lan, Ying
She, Bin
Mao, Bing
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 2017
[34] Efficacy of melatonin in the treatment of endometriosis: A phase II, randomized, double-blind, placebo-controlled trial
Schwertner, Andre
Conceicao dos Santos, Claudia C.
Costa, Gislene Dalferth
Deitos, Alicia
de Souza, Andressa
Custodio de Souza, Izabel Cristina
Torres, Iraci L. S.
da Cunha Filho, Joao Sabino L.
Caumo, Wolnei
PAIN, 2013, 154 (06) : 874 - 881
[35] The efficacy and safety of Codonopsis lanceolata water extract for sarcopenia: A study protocol for randomized, double-blind, placebo-controlled clinical trial
Park, Jaehyeon
Kim, Hyungsuk
Choung, Se-Young
Jeon, Yong Jae
Jeon, Hyo Jin
Youn, Sang Jun
Choi, Yong
Cho, Hong-Seok
Kang, Junhyuk
Seo, Yeonho
Kim, Koh-Woon
Song, Mi-Yeon
MEDICINE, 2022, 101 (39) : E30773
[36] Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study
Li, Yanpeng
Zhang, Ruoxi
Zhou, Yanling
Bao, Cungang
Lin, Zhaocun
Chen, Chunyan
He, Jingjing
Jin, Zhiping
Song, Lihua
Zhang, Min
Guo, Sigen
Jiang, Yu
Zhao, Zhongxin
SLEEP, 2024, 47 (02)
[37] Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial
Fang, Rui
Hu, Hua
Zhou, Yue
Wang, Shanshan
Mei, Zhigang
She, Ruining
Peng, Xiwen
Jiang, Qiling
Wang, Xiangyuan
Xie, Le
Lin, Hongyuan
Meng, Pan
Zhang, Kun
Wang, Wei
Xie, Yao
Liu, Litao
Tong, Jiao
Wu, Dahua
Luo, Yunhua
Liu, Chang
Lu, Yifang
Yu, Shangzhen
Cheng, Shaowu
Xu, Linyong
Fang, Zhuyuan
Shang, Hongcai
Ge, Jinwen
FRONTIERS IN PHARMACOLOGY, 2023, 13
[38] Efficacy and safety of undenatured type II collagen in patients with knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial
Alekseeva, Liudmila I.
Kashevarova, Natalia G.
Taskina, Elena A.
Strebkova, Ekaterina A.
Korotkova, Tatiana A.
Savushkina, Natalya M.
Sharapova, Evgeniia P.
Lila, Aleksander M.
Shostak, Nadezhda A.
Mazurov, Vadim I.
Nesterovich, Irina I.
Dedkova, Viktoriia A.
Vasilyuk, Vasiliy B.
V. Egorova, Natalia
Leontyeva, Marina A.
Yakupova, Svetlana P.
Vinogradova, Irina B.
Sorotskaya, Valentina N.
Shirokova, Larisa Yu.
TERAPEVTICHESKII ARKHIV, 2024, 96 (05) : 500 - 510
[39] The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial
Jeng, Jiann-Shing
Sun, Yu
Lee, Jiunn-Tay
Lin, Ruey-Tay
Chen, Chih-Hung
Po, Helen L.
Lin, Huey-Juan
Liu, Chung-Hsiang
Sun, Ming-Hui
Sun, Mu-Chien
Chern, Chang-Ming
Lien, Li-Ming
Chiu, Hou-Chang
Hu, Han-Hwa
Chiou, Hung-Yi
Chen, Sien-Tsong
Ma, Henry
Hsu, Chung Y.
INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (01) : 123 - 127
[40] Efficacy and safety of eculizumab in Guillain-Barré syndrome: A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial
Kuwabara, Satoshi
Kusunoki, Susumu
Kuwahara, Motoi
Yamano, Yoshihisa
Nishida, Yoichiro
Ishida, Hirokazu
Kasuya, Tomoyuki
Kupperman, Erik
Lin, Qun
Frick, Glen
Misawa, Sonoko
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 (03) : 339 - 349

← 1 2 3 4 5 →